Integral Diagnostics (ASX:IDX) Tax Expense: A$11.0 Mil (TTM As of Dec. 2025)


ASX:IDX Integral Diagnostics Ltd ASX:IDX
75 GF Score
Price A$2.00
GF Value A$2.78
Valuation Modestly Undervalued
! 9 Warning Signs
View Full Analysis

What is Integral Diagnostics Tax Expense?

Integral Diagnostics ASX:IDX 75 Tax Expense is A$11.0 Mil as of Dec. 2025. GuruFocus rates ASX:IDX with a GF Score™ of 75/100 and a GF Value™ of A$2.78 (Modestly Undervalued). The stock has 9 warning signs investors should review.

Integral Diagnostics's tax expense for the months ended in Dec. 2025 was A$5.0 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2025 was A$11.0 Mil.


Integral Diagnostics  (ASX:IDX) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Integral Diagnostics Tax Expense Related Terms


Integral Diagnostics Tax Expense Historical Data

* Premium members only.

The historical data trend for Integral Diagnostics's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Integral Diagnostics Tax Expense Chart

Integral Diagnostics Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.95 7.96 5.59 3.56 6.84

Integral Diagnostics Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.99 2.58 0.78 6.06 4.98
ASX:IDX
75GF Score
Integral Diagnostics Ltd ASX:IDX
Tax Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Integral Diagnostics Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$11.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Tax Expense →
What does a Tax Expense of A$11.0 Mil mean?
Integral Diagnostics (ASX:IDX) has a Tax Expense of A$11.0 Mil as of Dec. 2025. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Integral Diagnostics and its competitors.
Is Integral Diagnostics' Tax Expense too high?
Integral Diagnostics' current Tax Expense is A$11.0 Mil. Overall, Integral Diagnostics has a GF Score™ of 75/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Integral Diagnostics' Tax Expense compare to TMO and DHR?
Integral Diagnostics' Tax Expense of A$11.0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Tax Expense for a Medical Diagnostics & Research company?
A good Tax Expense depends on the Medical Diagnostics & Research industry context. However, Tax Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Tax Expense mean?
A high Tax Expense can signal that a stock is expensive relative to its fundamentals. Tax expense is the amount of tax the company pays in an accounting period. View historical data on Integral Diagnostics and its competitors. Integral Diagnostics's current Tax Expense is A$11.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Integral Diagnostics stock overvalued right now?
Based on GuruFocus' analysis, Integral Diagnostics (ASX:IDX) is currently considered Modestly Undervalued. The stock's GF Value™ is A$2.78, compared to a current price of A$2.00 — trading 28.1% below its estimated fair value. The current Tax Expense is A$11.0 Mil. Integral Diagnostics' overall GF Score™ is 75/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Tax Expense calculated?
Tax Expense is calculated from a company's financial statements. For Integral Diagnostics (ASX:IDX), the current Tax Expense is A$11.0 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Integral Diagnostics (ASX:IDX) Overvalued in 2026?

Based on GuruFocus' analysis, Integral Diagnostics stock appears to be undervalued. The current stock price of A$2.00 is trading 28.1% below its estimated GF Value™ of A$2.78. GuruFocus considers Integral Diagnostics to be Modestly Undervalued.

Key valuation signals for ASX:IDX:

  • Tax Expense: A$11.0 Mil
  • GF Value™: A$2.78 vs. price of A$2.00 (28.1% below fair value)
  • GF Score™: 75/100 with 9 warning signs

No single metric tells the full story. See the ASX:IDX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Integral Diagnostics Business Description

Address 288 Victoria Parade, Level 2, Melbourne, VIC, AUS, 3002
Integral Diagnostics is a major Australian diagnostic imaging provider. In Australia, imaging revenues are almost entirely earned via the public health Medicare system. Integral typically earns approximately 90% of group revenue from diagnostic imaging in Australia and the remainder from diagnostic imaging in Auckland, New Zealand. In Australia, Integral services regional areas in Queensland, Victoria, New South Wales, and Western Australia.
75GF Score

Get the complete analysis for ASX:IDX

Tax Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$2.00
Price
A$2.78
GF Value